NCT05848466 2026-03-30
Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients
Bio-Thera Solutions
Phase 1 Completed
Clinical Trials
11 trialsNCT04381650 2025-12-10
A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors
Takeda
Phase 1/2 Completed
NCT04572152 2025-02-28
A Study of AK119 (Anti-CD73) in Combination With AK104 in Subjects With Advanced Solid Tumors
Akeso
Phase 1 Completed
NCT01928394 2024-12-27
A Study of Nivolumab by Itself or Nivolumab Combined With Ipilimumab in Patients With Advanced or Metastatic Solid Tumors
Bristol-Myers Squibb
Phase 1/2 Completed
NCT02261532 2024-11-14
A Phase I Study of TAS-102 in Solid Tumors
Taiho Pharmaceutical Co., Ltd.
Phase 1 Completed
NCT03730337 2023-10-04
Phase 1 Study of ONO-7475 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors
Ono Pharmaceutical Co. Ltd
Phase 1 Completed
NCT03248843 2022-02-08
A Study of PD-L1 Antibody KN035 in Japanese Subjects With Locally Advanced or Metastatic Solid Tumors
3D Medicines
Phase 1 Completed
NCT02220049 2016-03-25
VELDAY
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1 Completed
NCT02004548 2015-12-29
Phase I Clinical Study of Metatinib Tromethamine Tablet
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1 Completed
NCT00276913 2014-02-03
A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors
Synta Pharmaceuticals Corp.
Phase 1 Completed
NCT01014429 2012-09-07
Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors
Nerviano Medical Sciences
Phase 1 Completed